Clinical Trials Browser

Phase 2/3 × Carcinoma, Non-Small-Cell Lung × Surgical Procedures, Operative × Clear all

NCT07076693 2025-07-22

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung